Optimization of Hepatic Hemodynamics During Liver Surgery

• Status: Completed
• Trial end date: 2017-03-20
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if vasopressin and nitroglycerin in combination will affect hepatic hemodynamics, in the setting of liver surgery.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sahlgrenska University Hospital, Sweden
• Treatments: Arginine Vasopressin; Nitroglycerin; Vasopressins

Criteria

Inclusion Criteria:

• Patients within ASA-class I-II scheduled for open liver resection

Exclusion Criteria:

• ASA-class III and IV, more than 2 medications for hypertension, BMI > 35, technical difficulties with insertion av catheters, extensive surgery.